205 related articles for article (PubMed ID: 34417287)
1. Dupilumab for STAT3-Hyper-IgE Syndrome With Refractory Intestinal Complication.
Lu CW; Lee WI; Chung WH
Pediatrics; 2021 Sep; 148(3):. PubMed ID: 34417287
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal Manifestations of STAT3-Deficient Hyper-IgE Syndrome.
Arora M; Bagi P; Strongin A; Heimall J; Zhao X; Lawrence MG; Trivedi A; Henderson C; Hsu A; Quezado M; Kleiner DE; Venkatesan AM; Holland SM; Freeman AF; Heller T
J Clin Immunol; 2017 Oct; 37(7):695-700. PubMed ID: 28803389
[TBL] [Abstract][Full Text] [Related]
3. Remission of eczema and recovery of Th1 polarization following treatment with Dupilumab in STAT3 hyper IgE syndrome.
Matucci-Cerinic C; Viglizzo G; Pastorino C; Corcione A; Prigione I; Bocca P; Bustaffa M; Cecconi M; Gattorno M; Volpi S
Pediatr Allergy Immunol; 2022 Apr; 33(4):e13770. PubMed ID: 35470938
[No Abstract] [Full Text] [Related]
4. Clearance of atypical cutaneous manifestations of hyper-IgE syndrome with dupilumab.
Nihal A; Comstock JR; Holland KE; Singh AM; Seroogy CM; Arkin LM
Pediatr Dermatol; 2022 Nov; 39(6):940-942. PubMed ID: 35734823
[TBL] [Abstract][Full Text] [Related]
5. Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome.
Sogkas G; Hirsch S; Jablonka A; Witte T; Schmidt RE; Atschekzei F
Clin Immunol; 2020 Jun; 215():108452. PubMed ID: 32360519
[No Abstract] [Full Text] [Related]
6. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
[TBL] [Abstract][Full Text] [Related]
7. Dupilumab treatment of eczema in a child with STAT3 hyper-immunoglobulin E syndrome.
Wang HJ; Yang TT; Lan CE
J Eur Acad Dermatol Venereol; 2022 May; 36(5):e367-e369. PubMed ID: 34927771
[No Abstract] [Full Text] [Related]
8. Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience.
Shamriz O; Rubin L; Simon AJ; Lev A; Barel O; Somech R; Korem M; Matza Porges S; Freund T; Hagin D; Garty BZ; Nahum A; Molho Pessach V; Tal Y
Front Immunol; 2022; 13():1044933. PubMed ID: 36605204
[TBL] [Abstract][Full Text] [Related]
9. Diverticulitis in a young man with hyper-IgE syndrome.
Stover DG; Freeman AF; Wright PW; Hummell DS; Ness RM
South Med J; 2010 Dec; 103(12):1261-3. PubMed ID: 21037522
[TBL] [Abstract][Full Text] [Related]
10. The treatment efficacy of dupilumab in autosomal dominant hyper-immunoglobulin E syndrome with severe atopic dermatitis.
Li W; Qi Q; Wang W; Li D
Asia Pac Allergy; 2024 Mar; 14(1):39-41. PubMed ID: 38482457
[TBL] [Abstract][Full Text] [Related]
11. Clinical Profile of Hyper-IgE Syndrome in India.
Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S
Front Immunol; 2021; 12():626593. PubMed ID: 33717144
[No Abstract] [Full Text] [Related]
12. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
13. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
[TBL] [Abstract][Full Text] [Related]
14. Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome.
Alonso-Bello CD; Jiménez-Martínez MDC; Vargas-Camaño ME; Hierro-Orozco S; Ynga-Durand MA; Berrón-Ruiz L; Alcántara-Montiel JC; Santos-Argumedo L; Herrera-Sánchez DA; Lozano-Patiño F; Castrejón-Vázquez MI
Case Reports Immunol; 2019; 2019():6357256. PubMed ID: 31355024
[TBL] [Abstract][Full Text] [Related]
15. Clinical Manifestation of Hyper IgE Syndrome Including Otitis Media.
Wu J; Hong L; Chen TX
Curr Allergy Asthma Rep; 2018 Aug; 18(10):51. PubMed ID: 30112673
[TBL] [Abstract][Full Text] [Related]
16. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: A long-term follow-up and genetic analysis.
Tavassoli M; Abolhassani H; Yazdani R; Ghadami M; Azizi G; Abdolrahim Poor Heravi S; Moeini Shad T; Kokabee M; Movahedi M; Abdshahzadeh H; Gharagozlou M; Rezaei N; Esmaeilzadeh H; Aleyasin S; Aghamohammadi A
Pediatr Allergy Immunol; 2019 Jun; 30(4):469-478. PubMed ID: 30801830
[TBL] [Abstract][Full Text] [Related]
17. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China.
Xie L; Hu X; Li Y; Zhang W; Chen L
Clin Dev Immunol; 2010; 2010():289873. PubMed ID: 20490271
[TBL] [Abstract][Full Text] [Related]
18. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
[TBL] [Abstract][Full Text] [Related]
19. Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S).
Liu JY; Li Q; Chen TT; Guo X; Ge J; Yuan LX
Eur J Pediatr; 2011 May; 170(5):661-6. PubMed ID: 21107604
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
